EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Factors affecting muscle strength in cancer patients receiving chemotherapy

Jiro Nakano, Shun Ishii, Takuya Fukushima, Ayumi Natsuzako, Junya Sakamoto, Minoru Okita

Journal of Novel Physiotherapy and Rehabilitation · 2017

DOI: 10.29328/journal.jnpr.1001008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Novel Physiotherapy and Rehabilitation, 2017. Verfasst von Jiro Nakano und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to investigate the relationship between muscle weakness and cancer-related symptoms in patients undergoing chemotherapy for hematological malignancies and solid tumors. We recruited hospitalized patients older than 20 years who were receiving chemotherapy. Patients were divided into a solid tumor (n=74) and hematological malignancy (n=80) group. Age, body mass index (BMI), strength and thickness of the quadriceps femoris muscle, serum albumin and C-reactive protein levels, blood hemoglobin concentration, fatigue, psychological distress and pain, and duration of hospitalization were assessed. Eight physical symptoms (fatigue, nausea and vomiting, pain, dyspnea, insomnia, appetite loss, constipation, and diarrhea) were also evaluated. Correlation and multiple regression analyses were conducted to identify factors affecting muscle strength in each group. Muscle strength was associated with fatigue in the solid tumor group and with age, BMI, muscle thickness, albumin and hemoglobin in the hematological malignancy group. Therefore, factors contributing to muscle strength might differ between patients with solid tumors and those with hematological malignancies. In particular, fatigue was an important factor in patients with solid tumors, while anemia was an important factor in patients with hematological malignancies. We therefore suggest that different treatments for muscle weakness might be considered for patients with these cancer types.

Zitieren

APA

Nakano, J., Ishii, S., Fukushima, T., Natsuzako, A., Sakamoto, J., & Okita, M. (2017). Factors affecting muscle strength in cancer patients receiving chemotherapy. Journal of Novel Physiotherapy and Rehabilitation. https://doi.org/10.29328/journal.jnpr.1001008

Vancouver

Nakano J, Ishii S, Fukushima T, Natsuzako A, Sakamoto J, Okita M. Factors affecting muscle strength in cancer patients receiving chemotherapy. Journal of Novel Physiotherapy and Rehabilitation. 2017. doi:10.29328/journal.jnpr.1001008

BibTeX
@article{Nakano2017,
  author = {Nakano, Jiro and Ishii, Shun and Fukushima, Takuya and Natsuzako, Ayumi and Sakamoto, Junya and Okita, Minoru},
  title = {Factors affecting muscle strength in cancer patients receiving chemotherapy},
  journal = {Journal of Novel Physiotherapy and Rehabilitation},
  year = {2017},
  doi = {10.29328/journal.jnpr.1001008}
}
Kostenlos starten →